Addiction News and Research

RSS

Abbott to acquire the global rights to PanGenetics' new therapeutic for treatment of chronic pain

PanGenetics, an antibody development company which is developing PG110, a humanized antibody to Nerve Growth Factor (NGF), today announced it has entered into an agreement with Abbott under which Abbott will acquire the global rights to this novel biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain.

13 Nov 2009

Bioniche Pharma acquires injectable drugs from Xanodyne Pharmaceuticals

Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the acquisition of Duraclon® (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals, Inc.

13 Nov 2009

Third-quarter 2009 results announced by Catalyst Pharmaceutical

Catalyst Pharmaceutical Partners, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

12 Nov 2009

Millennium Laboratories announces new clinical quantitative assay and drug screening tests for healthcare

Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today the company’s development and validation of a clinical quantitative assay for the new drug tapentadol (Nucynta™) by liquid chromatography/tandem mass spectrometry (LC-MS/MS).

12 Nov 2009

States are not taking enough efforts to help smokers quit: American Lung Association

As the debate over health care reform dominates the media and political arena, a new American Lung Association report finds that states aren't doing enough to help smokers quit - and policymakers must fix this in the health care reform process.

11 Nov 2009

Academic Health Center receives 128 grants totaling nearly $35 million in federal stimulus money

Academic Health Center scientists, physicians, and research centers have attracted 128 grants totaling nearly $35 million in federal stimulus money (as of Nov. 10) since the American Recovery and Reinvestment Act was approved in February 2009. This will result in a total economic impact of more than $105 million; according to the National Institutes of Health, $1 of research funding multiplies to more than $2 of goods and services in the economy.

11 Nov 2009

U.S. DOD grant to study vigabatrin in combination with opiates to manage pain

Catalyst Pharmaceutical Partners, Inc. today reported that a team of neuroscientists at The Feinstein Institute for Medical Research at North Shore-Long Island Jewish Health System (LIJ) has received a $1.2 million grant from the U.S. Department of Defense (DOD) to conduct an animal study of the use of vigabatrin in combination with opiates to effectively manage pain while reducing the potential for opiate addiction.

10 Nov 2009

Veterans don't ask for psychological help

They've seen horrors, experienced constant threats and survived traumatic events. Canada's military personnel often come back home with memories they'd rather forget. It's not scientifically understood why some soldiers develop post-traumatic stress disorder (PTSD) while others don't. However, many veterans simply don't ask for psychological help.

10 Nov 2009

NATC sponsored national quit smoking program to launch second phase of campaign

With the latest research estimating that nearly six million people worldwide will lose their lives to tobacco next year, an innovative approach is critical to helping the 43 million Americans who smoke to finally quit. This month, which is observed as Lung Cancer Awareness Month, the national quit smoking program, EX(R) will debut the second phase of advertising and promotions designed to help smokers "re-learn" life without cigarettes.

10 Nov 2009

Cannabinoid medicine: Challenges for health care providers and its potential benefits for patients

Groundbreaking articles in current issues of Journal of Opioid Management, for the first time explore, in depth, the emergence of cannabinoid medicine, its challenges for health care providers and its potential benefits for patients.

10 Nov 2009

New technology to help manage alcohol abuse and addiction among Veterans

As the country prepares to honor its military veterans November 11th, the Buffalo Veterans Treatment Court is employing a high-tech tool to help keep their community's struggling military veterans sober and accountable.

10 Nov 2009

Yo-yo dieting and sugar-bingeing can lead to anxiety and withdrawal symptoms

In research that sheds light on the perils of yo-yo dieting and repeated bouts of sugar-bingeing, researchers from The Scripps Research Institute have shown in animal models that cycling between periods of eating sweet and regular-tasting food can activate the brain's stress system and generate overeating, anxiety, and withdrawal-like symptoms.

10 Nov 2009

Tobacco smoke linked with respiratory diseases

Tobacco smoke is involved in uncontrolled asthma, a diminished response to anti-asthma drugs, rhinitis, nasal obstruction, and deregulation of the immune system according to an international expert at the annual meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Miami Beach, Fla.

9 Nov 2009

Health researchers speak about PTSD in light of Remembrance Day

6 Nov 2009

San Francisco and Berkeley miss opportunity to help smokers quit

San Francisco and Berkeley missed an opportunity to help smokers quit when the cities moved all tobacco sales out of pharmacies, according to a new Bay Area health initiative. Instead of having smokers buy cigarettes in convenience stores and at other retailers, smokers should buy cigarettes only at pharmacy counters, says Stuart Skorman, founder of Elephant Pharmacy.

6 Nov 2009

Grant awarded for research into a new treatment for methamphetamine addiction

Dr. Keith Flower - a research physician at the Addiction Pharmacology & Research Laboratory in San Francisco, CA - has been awarded a grant to investigate a new medication treatment for methamphetamine addiction. This grant has been awarded to California Pacific Medical Center's Research Institute through President Obama's AMERICAN RECOVERY AND REINVESTMENT ACT OF 2009.

6 Nov 2009

Re-classification of cannabis will have minimal impact on incidence of psychosis says study

The research follows last year’s decision by the UK government to reclassify the drug from class C to class B, partly out of concerns that cannabis, especially the more potent varieties, may increase the risk of schizophrenia in young people. However, the evidence for the relationship between cannabis and schizophrenia or psychosis remains controversial.

5 Nov 2009

Mandatory minimum sentences for drug-related offences, an ineffective approach

Mandatory minimum sentences for drug-related offences are an expensive and ineffective approach to substance use problems in Canada. That's the message being delivered today by an addictions professional at Canada's largest mental health and addictions treatment and research hospital to a Senate Committee on Bill C-15 - legislation that would create mandatory minimum sentences for certain drug-related offences.

5 Nov 2009

Health experts urge government authorities to declare a moratorium on new tobacco products

At the 6th Conference on Tobacco or Health being held in Montreal this week, numerous stakeholders are urging government authorities to declare a moratorium on new tobacco products to counter the innovative product launch and marketing strategies of cigarette manufacturers.

4 Nov 2009

NIH awards $4 million research grant to AllTranz

AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to advance the company’s transdermal tetrahydrocannabinol (THC) patch for the treatment of marijuana dependence and withdrawal.

3 Nov 2009